Overview
TENX market data
Price History
TENX price chart · 1M
- O
- 2.17
- H
- 2.22
- L
- 2.11
- C
- 2.18
- Vol
- 69,298.00
- Source
- US equities market feed
- Observed
- Aug 27, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $2.17
- Previous Close
- $2.13
- Day High
- $2.22
- Day Low
- $2.11
- 52 Week High
- $19.19
- 52 Week Low
- $1.32
- 7 Day Return
- +21.85%
- 30 Day Return
- -86.24%
- 90 Day Return
- -81.74%
- 1 Year Return
- -82.93%
- Daily Notional Volume
- $150.7K Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$1.34 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.97 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -10,115.8% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $1.31 – $19.40 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $64.9M · P/B 0.78 · P/S 1,317.05.
Company News
12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga · Aug 25, 2026, 5:06 PM
Chardan Capital Downgrades Tenax Therapeutics to Neutral, Lowers Price Target to $5Benzinga · Aug 11, 2026, 4:02 PM
Guggenheim Maintains Buy on Tenax Therapeutics, Lowers Price Target to $4Benzinga · Aug 11, 2026, 2:19 PM
Evercore ISI Group Downgrades Tenax Therapeutics to In-Line, Lowers Price Target to $5Benzinga · Aug 11, 2026, 12:38 PM
William Blair Downgrades Tenax Therapeutics to Market PerformBenzinga · Aug 10, 2026, 8:30 PM
Crude Oil Surges 3%; Sionna Therapeutics Shares PlungeBenzinga · Aug 10, 2026, 4:19 PM
Tenax Therapeutics Stock Dives as It Faces Heart Drug Study SetbackBenzinga · Aug 10, 2026, 4:02 PM
US Stocks Edge Lower; Monday.Com Shares Tumble After Q2 ResultsBenzinga · Aug 10, 2026, 1:40 PM
Tenax Therapeutics shares are trading lower after the company announced its Phase 3 LEVEL clinical trial evaluating TNX-103 did not meet its primary or key secondary endpoints.Benzinga · Aug 10, 2026, 12:36 PM
12 Health Care Stocks Moving In Monday's Pre-Market SessionBenzinga · Aug 10, 2026, 12:06 PM